GLP1R and diabetes mellitus: Nauck et al. (2021) [5] reported the effectiveness of GLP-1 receptor agonists in managing diabetes in obese patients, while Jensen et al. (2014) [6] highlighted the role of VLCD in reducing HbA1c levels pre-bariatric surgery.